StockData
AN2 Therapeutics, Inc. logo

AN2 Therapeutics, Inc. (ANTX) stock

ANTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$4.23−0.24 (-5.37%)

Close on Nov 17, 2026Market cap $159.62MP/E –Yield –

Earnings

AN2 Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 16, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$0.17
-$0.31 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of AN2 Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 16, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 9, 2026before the open––-$0.17Release
Q2 FY2026ended Jun 30, 2026Aug 11, 2026after the close–––Release
Q1 FY2026ended Mar 31, 2026May 11, 2026after the close––-$0.29Release
Q4 FY2025ended Dec 31, 2025Mar 17, 2026after the close––-$0.29Release
Q3 FY2025ended Sep 30, 2025Nov 12, 2025after the close––-$0.31Release
Q4 FY2024ended Dec 31, 2024Mar 25, 2025after the close––-$0.25Release
Q3 FY2024ended Sep 30, 2024Nov 13, 2024after the close–––Release
Q2 FY2024ended Jun 30, 2024Aug 13, 2024after the close–––Release
Q1 FY2024ended Mar 31, 2024May 14, 2024after the close––-$0.56Release
Q4 FY2023ended Dec 31, 2023Mar 28, 2024after the close––-$0.57Release
Q3 FY2023ended Sep 30, 2023Nov 9, 2023after the close––-$0.65Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

AN2 Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When AN2 Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases AN2 Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Update
  4. Results
  5. Results
  6. Update
  7. Results
  8. Update
  9. Update
  10. Results
  11. Results
  12. Results
  13. Update
  14. Results
  15. Results

See a number that looks wrong?